Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma

NCT00282100 is registered in ClinicalTrials.gov with Tan Tock Seng Hospital as lead sponsor.

NCT NCT00282100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00282100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma
Lead sponsor
Tan Tock Seng Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2005
Completion date
September 30, 2019
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer